[Latest] Global Cancer Immunotherapy Market Size/Share Worth USD 314.4 Billion by 2032 at a 7.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
March 28, 2024 15:30 ET
|
Custom Market Insights
Austin, TX, USA, March 29, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cancer Immunotherapy Market Size, Trends and Insights By Type of Immunotherapy...
Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications
March 26, 2024 08:30 ET
|
Dyadic International, Inc.
The first trial using a C1 produced monoclonal antibody provides equivalent protection against SARS-CoV-2 in hamster and nonhuman primate models compared to monoclonal antibody produced in CHO. ...
Vaccinex’s Next Generation ActivMAb® Technology Published in mAbs, a Leading Biotech Journal, and Validated in OmniAb Proof-of-Concept Collaboration
September 28, 2023 08:00 ET
|
Vaccinex, Inc.
Application is based on proprietary poxvirus system that enables Hard-to-Drug Complex Proteins to be expressed at high levels in their “native conformation” so as to efficiently induce and select...
Biopharmaceuticals Market Growth: Worth $700Bn by 2028 Led by Monoclonal Antibodies Held Market Share of 48.42% in 2022 | The Insight Partners
March 23, 2023 08:46 ET
|
The Insight Partners
New York, March 23, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Biopharmaceuticals Market Size, Share, Trends, Growth and Report Forecasts to 2028 - COVID-19 Impact and Global...
Medical Styrenic Polymer Market Projected to Expand at a CAGR of 5.7% from 2023 to 2030, According to Contrive Datum Insights
March 19, 2023 00:00 ET
|
Contrive Datum Insights Pvt Ltd
Farmington, March 19, 2023 (GLOBE NEWSWIRE) -- The Medical Styrenic Polymers Market is anticipated to progress at a CAGR of 5.7% during the forecast period 2022-2030. Polyvinyl chloride, or PVC, is...
Aridis Reports Top-Line Results of the Phase 3 Double-Blinded, Superiority Trial of AR-301 For the Treatment of Staphylococcus aureus Ventilator Associated Pneumonia (VAP)
January 25, 2023 16:05 ET
|
Aridis Pharmaceuticals, Inc.
LOS GATOS, Calif, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today announced top-line results from the AR-301-002 Phase 3 study, which evaluated the superiority of...
Aridis Pharmaceuticals to Discuss Topline Data from Phase 3 Study of AR-301 During Corporate Update Call on January 25
December 28, 2022 08:30 ET
|
Aridis Pharmaceuticals, Inc.
Los Gatos, Calif., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective...
Biologics Market Size is projected to reach USD 506 Billion by 2030, growing at a CAGR of 4%: Straits Research
June 23, 2022 09:15 ET
|
Straits Research
New York, United States, June 23, 2022 (GLOBE NEWSWIRE) -- The market for biologics is growing steadily because companies are spending a lot of money to improve the places where they make their...
Alzheimer’s Patient Advocates File FOIA Seeking Answers on Discriminatory Medicare Coverage Decision
April 15, 2022 11:42 ET
|
UsAgainstAlzheimer's
Washington, D.C., April 15, 2022 (GLOBE NEWSWIRE) -- Today, UsAgainstAlzheimer’s announced their latest effort to demand answers from the Centers for Medicare and Medicare Services (CMS) about last...
Antibody Therapy Market Revenue to hit $445 Billion by 2028, Says Global Market Insights Inc.
February 22, 2022 03:00 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Global antibody therapy market value projected to cross USD 445 billion by 2028, according to a new research report by Global Market...